PATENT CLAIM ANALYSIS

Application Number: 16335765
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-08
Patent Classification: ["546", "070000"]

Abstract:
A method for treating small cell lung cancer (SCLC). In the method, a therapeutically effective amount of a compound of Formula I: wherein R 1 , R 2  and R 3  have the definitions disclosed in the specification is administered alone or in combination with one or more anticancer agents, or surgery, radiation therapy, chemotherapy, and/or targeted therapy.

Claim (Index 9):
The method of  claim 8 , wherein:\n (i) R 1  is hydrogen; (ii) R 2  is ethyl; and/or (iii) R 3  is methyl.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13549572', '15745639', '13504943', '15309382', '11490438']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7719743202283629
- 35 USC 102 Novelty (BERT): 0.5468140622020023
- Combined Prediction Score: 0.7494582944257269
- Mean Citation Score: 272.06953000000004
- Max Citation Score: 401.5671
- Similarity Product: 268.1130417141974

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test